4.17 RCTs for Cancer Drug Approval with Dr. Saroj Niraula & Myeloma Studies with Dr. Manni Mohyuddin
We have two oncology conversations for you today.…
Plenary Session - inactive due to federal service · Plenary Session - inactive due to federal service
August 27, 202159m 1sExplicit
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
We have two oncology conversations for you today. The first is with Dr. Saroj Niraula of the University of Manitoba, and together we discuss the necessity of randomized controlled trials for granting FDA approval of cancer drugs. The second is with Dr. Ghulam Rehman "Manni" Mohyuddin of the University of Utah on a variety of myeloma studies, including LIGHTHOUSE, OCEANS, and HORIZON.
Feasibility of RCTs: doi.org/10.1093/jncics/pkab061
RR of Alternative Treatments: doi.org/10.1002/ijc.33231
Study Time Reduction: doi.org/10.1001/jamainternmed.2018.8351
Back us on Patreon! www.patreon.com/plenarysession
Check out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew
Topics
medicineoncologyhealthpolicy